Accueil>>Infectious Disease>> Bacterial Diseases>> MRSA>>Parvodicin C2

Parvodicin C2 (Synonyms: Antibiotic A40926 B1)

Catalog No.GC47924

A glycopeptide antibiotic

Products are for research use only. Not for human use. We do not sell to patients.

Parvodicin C2 Chemical Structure

Cas No.: 110882-85-4

Taille Prix Stock Qté
1 mg
43,00 $US
En stock
5 mg
194,00 $US
En stock
10 mg
342,00 $US
En stock
25 mg
750,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Parvodicin C2 is a glycopeptide antibiotic originally isolated from A. parvosata and a component of parvodicin complex .1 It is also a component of the A40926 antibiotic complex, which has been used as a precursor in the synthesis of the antibiotic dalbavancin .2 Parvodicin C2 is active against methicillin-sensitive strains of S. aureus, S. epidermidis, and S. saprophyticus (MICs = 0.4-12.5 μg/ml), as well as methicillin-resistant strains of S. aureus, S. hemolyticus, and E. faecalis (MICs = 0.2-50 μg/ml).1

1.Christensen, S.B., Allaudeen, H.S., Burke, M.R., et al.Parvodicin, a novel glycopeptide from a new species, Actinomadura parvosata: Discovery, taxonomy, activity and structure elucidationJ. Antibiot. (Tokyo)40(7)970-990(1987) 2.Jovetic, S., Feroggio, M., Marinelli, F., et al.Factors influencing cell fatty acid composition and A40926 antibiotic complex production in Nonomuraea sp. ATCC 39727J. Ind. Microbiol. Biotechnol.35(10)1131-1138(2008)

Avis

Review for Parvodicin C2

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Parvodicin C2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.